Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Artificial pancreas improves insulin control in children with diabetes

Researchers from the University of Virginia (UVA) have developed an artificial pancreas capable of delivering automated insulin to pediatric patients with type 1 diabetes. The study, presented at the Endocrine Society's 99th annual meeting, reports the artificial pancreas is significantly more effective in diabetes management than current methods.

Behavior assessment tool measures pain in nonverbal ICU patients

Measuring pain levels in critically ill patients, especially in those who cannot communicate verbally, is crucial in administering care. A study published in PAIN introduces a new behavior pain assessment tool (BPAT) capable of evaluating pain levels through nonverbal cues.

Spinal stimulation helps paralyzed man stand, make step-like movements

The pairing of electrical stimulation of the spinal cord and extensive physical therapy has given a man with paralyzed legs the ability to stand and make step-like movements.

Thumbnail

Hospital chargemaster rates linked to higher payments, but not higher quality care

The list prices for hospital procedures and tests aren’t “inconsequential,” according to economists, and can be associated with higher payments from insurers and patients. 

Iowa's top insurer Wellmark exiting individual market

Wellmark, the top health insurer in Iowa, will no longer sell plans on the individual market after this year, leaving some parts of the state in danger of having no insurer on the Affordable Care Act (ACA) exchanges for 2018.

Thumbnail

Medicare Advantage plans get better than expected rate hike for 2018

Payments to insurers offering Medicare Advantage plans will increase by an average of 0.45 percent, according to the final rate notice issued by CMS, above the 0.25 percent bump in pay the agency had previously proposed.

CMS: Medicaid DSH payments will consider what Medicare, third-party pay

In a final rule issued on March 30, CMS clarified uncompensated care costs for Medicaid patients are limited by what a hospital received from other sources, such as commercial insurers, Medicare or the patients themselves.

Thumbnail

ACHE 2017: Creating a provider-sponsored health plan means understanding your market

The lines are blurring between healthcare providers and payors as more providers are sponsoring their own health plans or partnering with payors. Unfortunately for interested providers, that greater prevalence hasn’t come with any one-size-fits-all approach for making these plans succeed.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.